surely someone knows more about the ann, just a resources upgrade is it?allot of confidence going into this considering it is a long weekend. will keep a close eye on this next week with a possible retrace for lower entry point.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling